We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Aviva Plc | LSE:AV. | London | Ordinary Share | GB00BPQY8M80 | ORD 32 17/19P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
10.60 | 2.25% | 482.60 | 481.60 | 481.80 | 484.00 | 473.70 | 478.80 | 4,938,343 | 16:35:19 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Insurance Carriers, Nec | 41.43B | 1.09B | 0.3962 | 12.16 | 13.19B |
Date | Subject | Author | Discuss |
---|---|---|---|
11/3/2016 11:35 | I don't really understand how Flanagan had such a high forecast for the divi and future growth but then also rated them as a sell beforehand. The amount of shares in issue is well known and so is the dilution with the friends deal. As the profits were higher than expected the EPS must have been higher and only the amount of distribution is a factor. I'll keep all mine. | dr biotech | |
11/3/2016 09:41 | Not sure if anyone applies the broker recs to their decision making?The median broker consensus for av. has been at 591p for some time.It'll never get there!Future earning potential looks strong - imo.Let's hope they keep the continuity going with the management team... | nicksoj | |
11/3/2016 09:32 | Aviva 2015 results: good, bad and warnings - Insurer Aviva (AV) delivered a set of results ‘with a smattering of good, bad and warnings’. Shore Capital analyst Eamonn Flanagan retained his ‘sell’ recommendation but does not have a target price on the stock following 2015 results. The shares rose 2.7% to 471.8p yesterday. He said the ‘good’ focused on the ‘Solvency II coverage ratio of 180%’, a measure of insurer’s financial strength, which was better than the 155% expected and ‘the operating profits were better than we and the market had expected’. The ‘bad’ was the 15% growth in the dividend to 20.8p. Flanagan said this was ‘well below our top-end 22p forecast and the market’s expectation of 21.2p’. He added that ‘the dilutive impact of the Friends Life deal is becoming evident and [there are] some forex hits’. The ‘warnings&rsqu ‘In addition the dividend growth is expected to moderate in the coming years. This compares to our forecast of c.15% per annum growth in earnings per shares for the next two years with a similar level of dividend growth attached,’ said Flanagan. | speedsgh | |
10/3/2016 10:49 | Results look good. Non life income not badly impacted by storm damage. Future looks bright other than referendum uncertainties. Presently very long but will open bearish positions shortly to close mid June. | alphorn | |
10/3/2016 10:02 | Dividend payment dates are buried somewhere within the plethora of results announcements. Probably quicker to look on their website which confirms XD 7/4 with payment on 17/5. EDIT - separate rns now released re dividend timetable... Dividend Declaration - | speedsgh | |
10/3/2016 09:34 | Or breakout to 520p. | philo124 | |
10/3/2016 08:57 | No one mention a gap. | uppompeii | |
10/3/2016 08:51 | Well PHILO subject to ECB today you should reach your target...... | bili1946 | |
10/3/2016 08:07 | Would be happier with share price through 485p. Overweight here. | philo124 | |
10/3/2016 07:37 | Yep, very good results! | philo124 | |
10/3/2016 07:35 | All seems good to me. Better cor divi up, strong capital position and integration on track.watch them plunge at open... Nice to see Wilson being upbeat too. He has previously understated and overly delivered. Onwards and upwards. | dr biotech | |
10/3/2016 07:27 | Stronger results with each year since the CEO change to Mark Wilson, just hope they can hang onto him. I'll have a few more of these before xd day. | spacecake | |
10/3/2016 07:21 | Great set of results divi up 15 percent | doc robinson | |
08/3/2016 14:11 | That's better ...you know the results are going to be stunning on Thursday.Well probably. | bili1946 | |
06/3/2016 13:59 | Should breach the 200 S.M.A. tonorrow. | philo124 | |
06/3/2016 10:13 | It looks like the pension reforms won't be going through, could give a lift on Monday.... | dr biotech | |
02/3/2016 11:37 | It went through my expected new high, but the opening gap up this morning is a little ominous. | idle dreamer | |
02/3/2016 08:12 | Results next Thursday, perhaps they'll include something in that. | laugher | |
02/3/2016 08:10 | Why didn't Aviva give an update following recent UK storms ? DLG thought it was prudent.Has cost guidance been blown away? | nicksoj | |
01/3/2016 22:23 | We have had a higher low so perhaps we now have a change of trend. But a slightly higher high would mean selling maybe late tomorrow at around 455 and buying again when it falls to 425 -ish. But maybe it would be better to stay invested. Who knows? Opinions please! | idle dreamer | |
17/2/2016 15:09 | Well, financials are starting the slow but sure lift back to reasonable valuation levels, and given how much they've been hammered, there's a good way to go yet; so despite my rant a while back about lack of customer service, I'm still holding Aviva, and other financials: Barclays being one. It must be a no-brainer buy right now, so take a look there too. | andrewbaker | |
12/2/2016 17:16 | if market recovers, likely scenario, a good share like this should recover fairly quickly back to 5 | and1 | |
12/2/2016 11:18 | Good day uppompeii This share price is not looking too bright but it is in good company there are plenty of others in similar situation. This needs to rise and hold above the last minor swing high at 425 as a first step to any recovery. | bracke |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions